Thomas L. Harrison
CIK: 0001247340
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 1, 2026AGEN
AGENUS INC
Award(A)Direct4.4K shares at avg. $6.89$31K - Aug 5, 2026AGEN
AGENUS INC
Award(A)DirectStock Option
50K shares- - Jul 1, 2026AGEN
AGENUS INC
Award(A)Direct8.5K shares at avg. $3.58$31K - Apr 24, 2026AGEN
AGENUS INC
Award(A)DirectStock Option
122.5K shares- - Apr 20, 2026ACXP
Acurx Pharmaceuticals, Inc.
Award(A)DirectStock Option
2.2K shares- - Apr 1, 2026AGEN
AGENUS INC
Award(A)Direct9.2K shares at avg. $3.32$31K - Jan 2, 2026AGEN
AGENUS INC
Award(A)Direct7.7K shares at avg. $3.98$31K - Nov 20, 2025AFCG
Advanced Flower Capital Inc.
Award(A)Direct5.5K shares at avg. $2.74$15K - Oct 1, 2025AGEN
AGENUS INC
Award(A)Direct5.8K shares at avg. $5.01$29K - Jul 1, 2025AGEN
AGENUS INC
Award(A)Direct7.4K shares at avg. $3.46$26K - Jun 17, 2025AGEN
AGENUS INC
Award(A)DirectStock Option
17.5K shares- - Apr 1, 2025AGEN
AGENUS INC
Award(A)Direct8.9K shares at avg. $2.88$26K - Feb 25, 2025AFCG
Advanced Flower Capital Inc.
Award(A)Direct1.8K shares at avg. $8.37$15K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  AGEN AGENUS INC | Award(A) | 4,443 | $6.89 | $30,626 | Direct |
| Aug 5, 2026 | AGEN AGENUS INC | Award(A) Stock Option | 50,000 | - | - | Direct |
| Jul 1, 2026 | AGEN AGENUS INC | Award(A) | 8,547 | $3.58 | $30,624 | Direct |
| Apr 24, 2026 | AGEN AGENUS INC | Award(A) Stock Option | 122,500 | - | - | Direct |
| Apr 20, 2026 |  ACXP Acurx Pharmaceuticals, Inc. | Award(A) Stock Option | 2,150 | - | - | Direct |
| Apr 1, 2026 | AGEN AGENUS INC | Award(A) | 9,228 | $3.32 | $30,628 | Direct |
| Jan 2, 2026 | AGEN AGENUS INC | Award(A) | 7,691 | $3.98 | $30,626 | Direct |
| Nov 20, 2025 |  AFCG Advanced Flower Capital Inc. | Award(A) | 5,474 | $2.74 | $14,999 | Direct |
| Oct 1, 2025 | AGEN AGENUS INC | Award(A) | 5,780 | $5.01 | $28,958 | Direct |
| Jul 1, 2025 | AGEN AGENUS INC | Award(A) | 7,401 | $3.46 | $25,622 | Direct |
| Jun 17, 2025 | AGEN AGENUS INC | Award(A) Stock Option | 17,500 | - | - | Direct |
| Apr 1, 2025 | AGEN AGENUS INC | Award(A) | 8,898 | $2.88 | $25,626 | Direct |
| Feb 25, 2025 | AFCG Advanced Flower Capital Inc. | Award(A) | 1,792 | $8.37 | $14,999 | Direct |
1-13 of 13 transactions
About HARRISON THOMAS L
HARRISON THOMAS L (SEC CIK 0001247340) files insider reports with the SEC as Director of AGENUS INC (AGEN), Director of Acurx Pharmaceuticals, Inc. (ACXP) and Director of Advanced Flower Capital Inc. (AFCG).
Signal8 holds 12 ownership filings by HARRISON THOMAS L, all Form 4s, filed between Feb 27, 2025 and Oct 2, 2026. Those filings report 13 transactions, from Feb 25, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HARRISON THOMAS L's filings is in LEXINGTON, MA.
Recent filings by HARRISON THOMAS L
- Oct 1, 2026: Grant or award of AGEN shares (Form 4, code A).
- Aug 5, 2026: Grant or award of AGEN derivative securities (Form 4, code A).
- Jul 1, 2026: Grant or award of AGEN shares (Form 4, code A).
- Apr 24, 2026: Grant or award of AGEN derivative securities (Form 4, code A).
- Apr 20, 2026: Grant or award of ACXP derivative securities (Form 4, code A).
Other insiders filing for AGENUS INC (AGEN)
- Wright Timothy, Director
- Marcucci Marco Tullio, Director
- ARMEN GARO H
- Corvese Brian, Director
- O'Day Steven J, Chief Medical Officer
- Hirsch Susan B, Director